Why the study?
Do third generation oral contraceptives increase the risk of venous thromboembolism compared to second generation oral contraceptives or no use in women aged 16-44?
Do third generation oral contraceptives increase the risk of venous thromboembolism compared to second generation oral contraceptives or no use in women aged 16-44?
Third generation oral contraceptives are associated with a slightly increased risk of venous thromboembolism compared to second generation products, highlighting the need for informed contraceptive choice.
No takes yet. Share an insight, caveat, or question.
May inform OC generation selection in VTE discussions; leaves open causality and needs prospective confirmation.
Duke-Elder et al. (1951) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: